BioScience Managers Capital Return on Healthcare Fund I Locks in 24.7% IRR for Investors

/in

Outstanding capital return in final distribution for Australian Bioscience Fund I  Australia’s best performing biotech fund in recent years as per Cambridge Associates ratings 13 August 2014: AusBiotech Industry Spotlight here. Leading Australian healthcare fund manager Bioscience Managers has maintained its exceptional performance by returning capital to investors from its Australian Bioscience Fund I at 24.7% […]

Read more

Rex Bionics awarded major research & development grant by NZ Government

/in ,

11 August 2014. Link here. Rex Bionics Plc (AIM: RXB), the developer and manufacturer of hands-free robotic exoskeletons for use by wheelchair users, today announces that its Auckland-based subsidiary Rex Bionics Ltd (RBL) has been awarded substantial new grant funding by the New Zealand Government to support the research and development of REX 3, the platform […]

Read more

SeaDragon Update: Edison Investment Research Releases SeaDragon Update

/in ,

NZX – market Information 7 August 2014. Link here. Edison Investment Research Releases SeaDragon Update Edison Investment Research has released a SeaDragon Corporate outlook that can be found attached to this release and also available on our website. Contact Ross Keeley SeaDragon Chief Executive Officer Telephone: 03 547 0336 About SeaDragon: www.seadragon.co.nz SeaDragon (NZX:SEA) is Australasia’s […]

Read more

Rex Bionics: Interim Results for six months ended 31 May 2014

/in ,

5 August 2014. Link here. Rex Bionics Plc (“Rex Bionics” or the “Company”) Maiden Interim Results for the six months ended 31 May 2014 5 August 2014, Rex Bionics Plc (RXB) (formerly Union MedTech Plc) the AIM-listed developer and manufacturer of hands-free robotic exoskeletons for use by wheelchair users, today announces its maiden unaudited results for […]

Read more

Rex Bionics: Appointment of Crispin Simon as CEO

/in ,

Released 5 August 2014. Link here. Rex Bionics Plc (“Rex Bionics” or the “Company”) Appointment of Crispin Simon as Chief Executive Officer Rex Bionics Plc (AIM: RXB), the developer and manufacturer of hands-free robotic exoskeletons for use by wheelchair users, today announces the appointment of Crispin Simon as Chief Executive Officer. Crispin, who has a 25-year […]

Read more

SeaDragon Appoints Independent Director – Patrick Geals

/in ,

Link here. 28 July 2014. SeaDragon Limited appoints Patrick Geals as a Non-Executive Independent Director SeaDragon Limited (SeaDragon), Australasia’s largest refiner and blender of high-quality internationally certified concentrated fish oils and fractions has appointed pharmaceutical and food industry expert Patrick Geals as a Non-Executive Independent Director. Welcoming Mr. Geals to the board, SeaDragon Chairman Dr. Doug […]

Read more

Nexus6’s Smartinhaler Dramatically Improves Medication Adherence

/in ,

Link here. July 23rd, 2014. Results published today in the prestigious Journal of Allergy and Clinical Immunology (JACI) announce a ground-breaking increase in adherence with asthma medications for patients provided with a novel device called the Smartinhaler, manufactured by digital health company Nexus6 Ltd. The research was conducted by the highly regarded Woolcock Institute of Medical Research […]

Read more

REX to exhibit at the Hamlyn Symposium on Medical Robots

/in ,

Released : 10 July 2014 RNS Number : 8968L Link here.   REX to exhibit at the Hamlyn Symposium on Medical Robots Rex Bionics plc (AIM: RXB), the developer and manufacturer of REX products: hands-free robotic exoskeletons for use by wheelchair users, announces that it will be exhibiting at the 7th Hamlyn Symposium on Medical Robots, at the […]

Read more

Nexus6 – Sleeper medical technology company stirs.

/in ,

Friday June 27, 2014. The National Business Review article link here. A local sleeper medical technology company has ambitious plans to move into commercial production, and won’t rule out an initial public offering. Reporter David Williams looks into how the up and coming tech company are developing a smart device to remotely monitor how people with asthma and other […]

Read more

SeaDragon Investor Presentation June 2014

/in ,

Link here. Presentation overview: • FY2014 Financial Review • The Market / Industry Overview • Business Update

Read more